Showing results (531-540 of 601) with videos related to

Sort By:
Pageof 61
Cells|April 11, 2025
Effects of Anti-CD20 Antibody Therapy on Immune Cell Dynamics in Relapsing-Remitting Multiple SclerosisAlice G Willison, Ramona Hagler, Margit Weise, et al.
Neurology|September 17, 2017
Reversibility of the effects of natalizumab on peripheral immune cell dynamics in MS patientsTatiana Plavina, Kumar Kandadi Muralidharan, Geoffrey Kuesters, et al.
The New England Journal of Medicine|December 22, 2016
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple SclerosisStephen L Hauser, Amit Bar-Or, Giancarlo Comi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 14, 2014
Natalizumab exerts a suppressive effect on surrogates of B cell function in blood and CSFClemens Warnke, Mark Stettner, Vera Lehmensiek, et al.
The New England Journal of Medicine|December 22, 2016
Ocrelizumab versus Placebo in Primary Progressive Multiple SclerosisXavier Montalban, Stephen L Hauser, Ludwig Kappos, et al.
Ebiomedicine|November 12, 2022
Association between B-cell depletion and attack risk in neuromyelitis optica spectrum disorder: An exploratory analysis from N-MOmentum, a double-blind, randomised, placebo-controlled, multicentre phase 2/3 trialJeffrey L Bennett, Orhan Aktas, William A Rees, et al.
The Lancet. Neurology|July 10, 2019
Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trialDiego Cadavid, Michelle Mellion, Raymond Hupperts, et al.
Multiple Sclerosis and Related Disorders|February 15, 2022
AQP4-IgG-seronegative patient outcomes in the N-MOmentum trial of inebilizumab in neuromyelitis optica spectrum disorderRomain Marignier, Sean J Pittock, Friedemann Paul, et al.
Journal of the Peripheral Nervous System : JPNS|January 24, 2019
Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studiesIngemar S J Merkies, Ivo N van Schaik, Jean-Marc Léger, et al.
Scientific Reports|August 23, 2025
Flecainide mediated sodium channel blockade enhances blood brain barrier integrity and promotes neuroprotection in neuroinflammationMustafa Sindi, Diana Klees, Vera Dobelmann, et al.
Pageof 61